Lung cancer remains one of the most ominous health threats worldwide, capturing ...
A groundbreaking study published by researchers from Columbia University and the...
Fibroblast Activation Protein PET Imaging: A New Era in Oncology and Beyond In r...
The Future of Spine Surgery: University Hospitals Introduces Endoscopic Spine Su...
In a groundbreaking study from Tokyo Metropolitan University, a team of research...
Microbial agents within the Amazon rainforest have significantly contributed to ...
Tiny plastic particles pervade nearly every corner of our planet, from remote oc...
Disc Medicine has finalized the design for its confirmatory trial of bitopertin,...
Atara Biotherapeutics has now faced a second setback after getting a complete re...
Chinese biotechs InnoCare Pharma and KeyMed Biosciences have licensed the intern...
Disc Medicine finalised the pivotal Phase III trial design of bitopertin in eryt...
The FDA reported that six patients died after being injected with Teva’s Copaxon...
Emcure Pharmaceuticals has opened its new formulation research and development (...
AbbVie and Neomorph are set to enter a partnership and option-to-license agreeme...
The Pharmaceutical Technology Excellence Awards winners have been announced! Dow...
The year ahead in clinical trials looks set to be one that is challenged and inf...
